ArticleMedicine2020

Adverse cardiac events in the treatment of non-small cell lung cancer with programmed death-1and programmed death-ligand 1 inhibitors: A protocol for systematic review and meta-analysis.

Honglin Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.